Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
The Journal of Allergy and Clinical Immunology
|
May 26, 2026
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis - STEPIn Mechanistic Sub-study results
Johann E Gudjonsson, Katharina Bier, Swann Gaulis, et al.
Nature Communications
|
December 4, 2014
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Roberto Lande, Elisabetta Botti, Camilla Jandus, et al.
Science Immunology
|
January 20, 2019
Human "T<sub>H</sub>9" cells are a subpopulation of PPAR-γ<sup>+</sup> T<sub>H</sub>2 cells
Claire Micossé, Leonhard von Meyenn, Oliver Steck, et al.
Nature Communications
|
June 30, 2023
Differentiation of IL-26<sup>+</sup> T<sub>H</sub>17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis
Anissa Fries, Fanny Saidoune, François Kuonen, et al.
Nature Immunology
|
December 6, 2017
Diversification of human plasmacytoid predendritic cells in response to a single stimulus
Solana G Alculumbre, Violaine Saint-André, Jeremy Di Domizio, et al.
Journal of the American Academy of Dermatology
|
February 22, 2019
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
Tiago Torres, Anna Balato, Curdin Conrad, et al.
Nature Immunology
|
July 14, 2015
T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
Stephan Meller, Jeremy Di Domizio, Kui S Voo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 12, 2023
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT)
Fabio Verardi, Lara Valeska Maul, Kim Borsky, et al.
The Journal of Dermatological Treatment
|
September 27, 2019
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
Andrea Chiricozzi, Anna Balato, Curdin Conrad, et al.
The Journal of Experimental Medicine
|
April 14, 2025
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains
Fanny Saidoune, Danyel Lee, Jeremy Di Domizio, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
The Journal of Allergy and Clinical Immunology
|
May 26, 2026
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis - STEPIn Mechanistic Sub-study results
Johann E Gudjonsson, Katharina Bier, Swann Gaulis, et al.
Nature Communications
|
December 4, 2014
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Roberto Lande, Elisabetta Botti, Camilla Jandus, et al.
Science Immunology
|
January 20, 2019
Human "T<sub>H</sub>9" cells are a subpopulation of PPAR-γ<sup>+</sup> T<sub>H</sub>2 cells
Claire Micossé, Leonhard von Meyenn, Oliver Steck, et al.
Nature Communications
|
June 30, 2023
Differentiation of IL-26<sup>+</sup> T<sub>H</sub>17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis
Anissa Fries, Fanny Saidoune, François Kuonen, et al.
Nature Immunology
|
December 6, 2017
Diversification of human plasmacytoid predendritic cells in response to a single stimulus
Solana G Alculumbre, Violaine Saint-André, Jeremy Di Domizio, et al.
Journal of the American Academy of Dermatology
|
February 22, 2019
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
Tiago Torres, Anna Balato, Curdin Conrad, et al.
Nature Immunology
|
July 14, 2015
T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
Stephan Meller, Jeremy Di Domizio, Kui S Voo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 12, 2023
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT)
Fabio Verardi, Lara Valeska Maul, Kim Borsky, et al.
The Journal of Dermatological Treatment
|
September 27, 2019
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
Andrea Chiricozzi, Anna Balato, Curdin Conrad, et al.
The Journal of Experimental Medicine
|
April 14, 2025
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains
Fanny Saidoune, Danyel Lee, Jeremy Di Domizio, et al.
Page
of 12